L-2-Hydroxyglutarate production arises from noncanonical enzyme function at acidic pH
Andrew M Intlekofer1,2, Bo Wang1, Hui Liu3
1Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Nature Chemical Biology
|March 7, 2017
Summary
Lactate dehydrogenase (LDH) and malate dehydrogenase (MDH) can produce L-2-hydroxyglutarate (L-2HG) from alpha-ketoglutarate (αKG). Acidic conditions boost L-2HG production, stabilizing HIF-1α in normoxia.
Area of Science:
- Biochemistry
- Cell Biology
- Metabolomics
Background:
- 2-hydroxyglutarate (2HG) exists as D- and L-enantiomers, inhibiting α-ketoglutarate (αKG)-dependent enzymes.
- Oncogenic IDH mutations produce D-2HG, blocking cell differentiation.
- L-2HG accumulates under hypoxia, aiding physiologic adaptation.
Purpose of the Study:
- Investigate stereospecific L-2HG production by LDH and MDH.
- Determine the role of acidic pH in L-2HG generation.
- Elucidate the link between L-2HG and HIF-1α stabilization.
Main Methods:
- Enzymatic assays using purified LDH and MDH.
- Analysis of αKG reduction and L-2HG production.
- Assessment of HIF-1α stabilization under varying pH conditions.
Main Results:
- LDH and MDH stereospecifically produce L-2HG from αKG.
- Acidic pH enhances L-2HG production by promoting αKG binding to LDHA.
- Acid-enhanced L-2HG stabilizes HIF-1α in normoxia.
Conclusions:
- LDH and MDH exhibit promiscuous activity toward αKG, generating L-2HG.
- Microenvironmental acidity influences L-2HG production and cellular responses.
- Metabolite production by enzymes can be modulated by pH, impacting cell fate.
Related Concept Videos
Fates of Pyruvate
11.8K
Pyruvate is the end product of glycolysis, where glucose is oxidized to pyruvate, simultaneously reducing NAD+ to NADH. Two molecules of ATP are also produced by substrate-level phosphorylation.
In aerobic organisms, pyruvate is metabolized via the citric acid cycle to produce reduced coenzymes NADH and FADH2. These coenzymes are then oxidized in the electron transport chain to produce ATP and, in the process, regenerate the NAD+ and FAD. As seen in some cell types and organisms, fermentation...
In aerobic organisms, pyruvate is metabolized via the citric acid cycle to produce reduced coenzymes NADH and FADH2. These coenzymes are then oxidized in the electron transport chain to produce ATP and, in the process, regenerate the NAD+ and FAD. As seen in some cell types and organisms, fermentation...
11.8K
Allosteric Proteins-ATCase
6.8K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.8K
Drug Metabolism: Phase II Reactions
5.4K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
5.4K
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
1.1K
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
1.1K
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
1.1K
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
1.1K
Phase II Reactions: Glucuronidation
1.9K
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
1.9K


